Biomarin Pharmaceutical Inc (BMRN)
Return on total capital
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 254,532 | 205,898 | 166,541 | 123,868 | 88,013 | 165,546 | 116,750 | 71,685 | 50,948 | -60,013 | -39,396 | -48,725 | -100,923 | -19,688 | 19,572 | 83,950 | 83,146 | -71,351 | -104,065 | -124,106 |
Long-term debt | US$ in thousands | 593,605 | 593,095 | 592,586 | 1,084,990 | 1,084,010 | 1,083,020 | 1,082,030 | 1,081,050 | 1,080,060 | 1,079,080 | 1,078,090 | 1,077,110 | 1,076,130 | 1,075,140 | 1,074,160 | 1,073,200 | 486,713 | 486,238 | 843,616 | 839,165 |
Total stockholders’ equity | US$ in thousands | 5,073,820 | 4,951,550 | 4,896,900 | 4,782,830 | 4,659,040 | 4,603,160 | 4,568,510 | 4,499,740 | 4,386,240 | 4,265,670 | 4,261,080 | 4,236,500 | 4,162,010 | 4,100,930 | 4,053,890 | 3,236,680 | 3,239,960 | 3,122,380 | 3,074,400 | 2,960,950 |
Return on total capital | 4.49% | 3.71% | 3.03% | 2.11% | 1.53% | 2.91% | 2.07% | 1.28% | 0.93% | -1.12% | -0.74% | -0.92% | -1.93% | -0.38% | 0.38% | 1.95% | 2.23% | -1.98% | -2.66% | -3.27% |
March 31, 2024 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $254,532K ÷ ($593,605K + $5,073,820K)
= 4.49%
Biomarin Pharmaceutical Inc's return on total capital has exhibited fluctuating trends over the past several quarters. The return on total capital ranged from -3.27% in Jun 2019 to a peak of 4.49% in Mar 2024. Overall, there has been a general upward trend in the return on total capital, with a few exceptions of negative returns in some quarters.
The return on total capital indicates the company's ability to generate profits from the total capital invested in the business, including both debt and equity. The increasing trend in the return on total capital suggests that the company may be improving its operational efficiency and generating higher returns on the capital employed.
However, it is important to note that the return on total capital can be influenced by various factors such as changes in profitability, asset utilization, and capital structure. Further analysis of the company's financial statements and business operations would provide a more in-depth understanding of the factors driving the changes in the return on total capital.
Peer comparison
Mar 31, 2024